日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacodynamic studies of taniborbactam (VNRX-5133) combined with cefepime against β-lactamase-producing Gram-negative bacteria in a neutropenic murine thigh infection model

在嗜中性粒细胞减少的小鼠大腿感染模型中,对坦尼博巴坦(VNRX-5133)联合头孢吡肟治疗产β-内酰胺酶革兰氏阴性菌感染的药效学研究

Georgiou, Panagiota-Christina; Siopi, Maria; Tsala, Marilena; Lagarde, Claudia; Kloezen, Wendy; Muller, Anouk E; Meletiadis, Joseph

The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions

NOSO-502药效学指标的大小:病原体清除、耐药性的出现和人体剂量预测

van den Berg, Sanne; Attwood, Marie; Griffin, Pippa; Noel, Alan; Das, Shampa; Zeitlinger, Markus; Racine, Emilie; Boulenc, Xavier; Muller, Anouk E; Sassen, Sebastiaan D T; Bahmany, Soma; Ten Kate, Marian T; MacGowan, Alasdair; Meletiadis, Joseph

The pharmacodynamics of polymyxin B in Acinetobacter baumannii in murine thigh and lung infection models

多粘菌素B在鲍曼不动杆菌小鼠大腿和肺部感染模型中的药效学研究

van den Berg, Sanne; Pieren, Michel; Sassen, Sebastiaan D T; de Jong, Willem A M; Boonman, Catharina S C; Dale, Glenn E; Muller, Anouk E

A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta-Lactamase Inhibition

克拉维酸口服和静脉注射在新生儿和婴儿中的群体药代动力学研究:靶向有效抑制β-内酰胺酶

Schouwenburg, Stef; Keij, Fleur M; Tramper-Stranders, Gerdien A; Kornelisse, René F; Reiss, Irwin K M; De Cock, Pieter A J G; Dhont, Evelyn; Watt, Kevin M; Muller, Anouk E; Flint, Robert B; Koch, Birgit C P; Allegaert, Karel; Preijers, Tim

The synergistic effect of the combination of polymyxin B and rifampicin in a murine neutropenic thigh infection model with E. coli and K. pneumoniae.

在小鼠中性粒细胞减少性大腿感染大肠杆菌和肺炎克雷伯菌模型中,多粘菌素 B 和利福平联合用药具有协同作用

Van Den Berg Sanne, Sassen Sebastiaan D T, Couet William, Marchand Sandrine, Van Der Spek Heleen, Ten Kate Marian T, Meletiadis Joseph, Muller Anouk E

Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape

从药代动力学角度探讨抗菌药物剂量个体化:现状概述

Preijers, Tim; Muller, Anouk E; Abdulla, Alan; de Winter, Brenda C M; Koch, Birgit C P; Sassen, Sebastiaan D T

Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?

美罗培南模型指导下的精准给药在危重症患者治疗中能否应用?

Li, Letao; Sassen, Sebastiaan D T; Ewoldt, Tim M J; Abdulla, Alan; Hunfeld, Nicole G M; Muller, Anouk E; de Winter, Brenda C M; Endeman, Henrik; Koch, Birgit C P

Clinical Experience with Off-Label Intrathecal Administration of Selected Antibiotics in Adults: An Overview with Pharmacometric Considerations

成人非适应症鞘内注射特定抗生素的临床经验:概述及药代动力学考量

Muller, Anouk E; van Vliet, Peter; Koch, Birgit C P

Pharmacodynamics of Temocillin in Neutropenic Murine Infection Models

替莫西林在嗜中性粒细胞减少小鼠感染模型中的药效学

Muller, Anouk E; Raaphorst, Merel; van der Meijden, Aart; de Winter, Brenda C M; Meletiadis, Joseph; van den Berg, Sanne

Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models

多粘菌素B在大肠杆菌和肺炎克雷伯菌小鼠感染模型中的药代动力学和药效学特性

van der Meijden, Aart; Aranzana-Climent, Vincent; van der Spek, Heleen; de Winter, Brenda C M; Couet, William; Meletiadis, Joseph; Muller, Anouk E; van den Berg, Sanne